Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered Advanced/Metastatic Non-small Cell Lung Cancer: a Prospective, Observational Study

NCT07516015 is registered in ClinicalTrials.gov with Nanjing Tianyinshan Hospital as lead sponsor.

NCT NCT07516015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered Advanced/Metastatic Non-small Cell Lung Cancer: a Prospective, Observational Study
Lead sponsor
Nanjing Tianyinshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 10, 2026
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc